Literature DB >> 20191511

Pregnancy outcomes in women with familial Mediterranean fever receiving colchicine: is amniocentesis justified?

Eli Ben-Chetrit1, Avraham Ben-Chetrit, Yackov Berkun, Eldad Ben-Chetrit.   

Abstract

OBJECTIVE: To evaluate the outcome of pregnancies in women with familial Mediterranean fever (FMF) who are taking colchicine, and to reconsider the justification for amniocentesis in these women.
METHODS: The outcome of 179 pregnancies in a group of women with FMF taking colchicine was compared with the outcome of 197 pregnancies in women with FMF who did not take colchicine during pregnancy and with 312 pregnancies in another cohort of healthy pregnant women of similar age and ethnicity.
RESULTS: There was no difference in the 3 groups regarding early abortions, late abortions, or congenital malformations. There was a mild trend towards a better outcome for the colchicine-treated group but these results did not reach statistical significance.
CONCLUSION: Treatment with colchicine during pregnancy in patients with FMF is beneficial in controlling the disease while not affecting the outcome of the pregnancy; therefore there is no justification for recommending amniocentesis in women taking colchicine solely because of this treatment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20191511     DOI: 10.1002/acr.20061

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  10 in total

Review 1.  Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review.

Authors:  Erkan Demirkaya; Burak Erer; Seza Ozen; Eldad Ben-Chetrit
Journal:  Rheumatol Int       Date:  2015-12-19       Impact factor: 2.631

2.  [IL-1-blockade with Anakinra during pregnancy : Retrospective analysis of efficacy and safety in female patients with familial Mediterranean fever].

Authors:  N Venhoff; R E Voll; C Glaser; J Thiel
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

Review 3.  Familial Mediterranean fever: An updated review.

Authors:  İsmail Sarı; Merih Birlik; Timuçin Kasifoğlu
Journal:  Eur J Rheumatol       Date:  2014-03-01

Review 4.  The impact of familial Mediterranean fever on reproductive system.

Authors:  Muyesser Nergiz Yanmaz; Ayşet Jane Özcan; Kadir Savan
Journal:  Clin Rheumatol       Date:  2014-06-14       Impact factor: 2.980

5.  Familial mediterranean fever: assessment of clinical manifestations, pregnancy, genetic mutational analyses, and disease severity in a national cohort.

Authors:  Hatice Bodur; Fatma Gül Yurdakul; Hasan Fatih Çay; Ülkü Uçar; Yaşar Keskin; Betül Sargın; Gülcan Gürer; Ozan Volkan Yurdakul; Mustafa Çalış; Hülya Deveci; Yıldıray Aydın; Sami Hizmetli; Remzi Çevik; Ali Yavuz Karahan; İsmihan Sunar; Mehmet Tuncay Duruöz; Hilal Ecesoy; Zafer Günendi; Murat Toprak; Nesrin Şen; Duygu Altıntaş; Ahmet Kıvanç Cengiz; Gökhan Çağlayan; Ali Nail Demir; Hüseyin Kaplan; Sertaç Ketenci; Meltem Alkan Melikoğlu; Mehmet Nayimoğlu; Kemal Nas; Ayşe Banu Sarıfakıoğlu; İlhan Sezer
Journal:  Rheumatol Int       Date:  2019-09-14       Impact factor: 2.631

Review 6.  Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management.

Authors:  Seza Özen; Ezgi Deniz Batu; Selcan Demir
Journal:  Front Immunol       Date:  2017-03-23       Impact factor: 7.561

Review 7.  Update on the management of colchicine resistant Familial Mediterranean Fever (FMF).

Authors:  Georges El Hasbani; Ali Jawad; Imad Uthman
Journal:  Orphanet J Rare Dis       Date:  2019-10-15       Impact factor: 4.123

Review 8.  Inflammasome Targeted Therapy in Pregnancy: New Insights From an Analysis of Real-World Data From the FAERS Database and a Systematic Review.

Authors:  Carla Carnovale; Enrico Tombetti; Vera Battini; Faizan Mazhar; Sonia Radice; Mariangela Nivuori; Enrica Negro; Silvia Tamanini; Antonio Brucato
Journal:  Front Pharmacol       Date:  2021-01-20       Impact factor: 5.810

Review 9.  A Systematic Review of the Safety of Blocking the IL-1 System in Human Pregnancy.

Authors:  Marie-Eve Brien; Virginie Gaudreault; Katia Hughes; Dexter J L Hayes; Alexander E P Heazell; Sylvie Girard
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.964

Review 10.  Rheumatologic Medication Use During Pregnancy.

Authors:  Emily A Peterson; Jessica Lynton; Allison Bernard; Mark K Santillan; Brittany Bettendorf
Journal:  Obstet Gynecol       Date:  2020-05       Impact factor: 7.661

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.